Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/7725
Email LibraryRMU.DOH@nt.gov.au to ask for this document in a different format
Title: Thymic hyperplasia following double immune checkpoint inhibitor therapy in two patients with stage IV melanoma.
Authors: Mencel, Justin
Gargett, Tessa
Karanth, Narayan
Pokorny, Adrian
Brown, Michael P
Charakidis, Michail
Citation: Asia-Pacific journal of clinical oncology 2019-08-01
Abstract: Hyperplasia of the thymus is commonly seen in myasthenia gravis and other autoimmune disorders. Thymic size also varies with age, corticosteroid use, infections, and inflammatory disease. Although thymic hyperplasia has been described following chemotherapy, there is no known association of true thymic hyperplasia with immune checkpoint inhibitor therapy. We present two cases of suspected true thymic hyperplasia in patients with stage IV melanoma who were treated with the combination of nivolumab and ipilimumab, which was complicated by immune-related toxicity requiring corticosteroid therapy, and then subsequently also by secondary hypoadrenalism requiring replacement hydrocortisone. In one patient, histological and flurocytometric analyses of an incisional biopsy of the thymus revealed findings consistent with true thymic hyperplasia. In the other case, the stable fluorodeoxyglucose positron emission tomography/Computed tomography (FDG-PET/CT) findings were consistent also with true thymic hyperplasia. These are the first described cases of true thymic hyperplasia following combination immune checkpoint inhibitor therapy for metastatic melanoma. We hypothesize that the true thymic hyperplasia in these cases results from initial lymphocyte depletion caused by intense corticosteroid therapy followed by rebound thymic hyperplasia during the period of relative hypocortisolism, which may have been aggravated by the onset of secondary hypoadrenalism.
Click to open PubMed article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/31373116
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/31373116
Journal title: Asia-Pacific journal of clinical oncology
Publication Date: 2019-08-01
Type: Case Reports
URI: https://hdl.handle.net/10137/7725
DOI: 10.1111/ajco.13233
metadata.dc.identifier.orcid: https://orcid.org/0000-0002-1097-7953
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.